Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT01339286 · UNKNOWN

Trial details

NCT number: NCT01339286
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2011-03-01
Primary completion: 2011-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.